Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Baralle

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Clinical Endocrinology|November 6, 2007
Identification and characterization of four PAX8 rare sequence variants (p.T225M, p.L233L, p.G336S and p.A439A) in patients with congenital hypothyroidism and dysgenetic thyroid glandsSebastián A Esperante, Carina M Rivolta, Lucrecia Miravalle, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2016
Antimycobacterial activity of new N(1)-[1-[1-aryl-3-[4-(1H-imidazol-1-yl)phenyl]-3-oxo]propyl]-pyridine-2-carboxamidrazone derivativesDaniele Zampieri, Maria Grazia Mamolo, Luciano Vio, et al.
FEBS Letters|July 28, 2006
NF1 mRNA biogenesis: effect of the genomic milieu in splicing regulation of the NF1 exon 37 regionMarco Baralle, Natasa Skoko, Anna Knezevich, et al.
Disease Models & Mechanisms|March 4, 2022
Physiological tissue-specific and age-related reduction of mouse TDP-43 levels is regulated by epigenetic modificationsMiriam Pacetti, Laura De Conti, Luciano E Marasco, et al.
Nucleic Acids Research|December 27, 2013
Predominance of spliceosomal complex formation over polyadenylation site selection in TDP-43 autoregulationSara Bembich, Jeremias S Herzog, Laura De Conti, et al.
Experimental & Molecular Medicine|July 31, 2024
Tailored antisense oligonucleotides designed to correct aberrant splicing reveal actionable groups of mutations for rare genetic disordersHtoo A Wai, Eliska Svobodova, Natalia Romero Herrera, et al.
Human Mutation|July 17, 2010
Congenital insensitivity to pain: novel SCN9A missense and in-frame deletion mutationsJames J Cox, Jony Sheynin, Zamir Shorer, et al.
The EMBO Journal|December 7, 2010
TDP-43 regulates its mRNA levels through a negative feedback loopYouhna M Ayala, Laura De Conti, S Eréndira Avendaño-Vázquez, et al.
Translational Oncology|March 25, 2022
Force-feeding malignant mesothelioma stem-cell like with exosome-delivered miR-126 induces tumour cell killingFederica Monaco, Laura De Conti, Simone Vodret, et al.
Neurobiology of Disease|September 27, 2021
Thioridazine reverts the phenotype in cellular and Drosophila models of amyotrophic lateral sclerosis by enhancing TDP-43 aggregate clearanceLucia Cragnaz, Greta Spinelli, Laura De Conti, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Clinical Endocrinology|November 6, 2007
Identification and characterization of four PAX8 rare sequence variants (p.T225M, p.L233L, p.G336S and p.A439A) in patients with congenital hypothyroidism and dysgenetic thyroid glandsSebastián A Esperante, Carina M Rivolta, Lucrecia Miravalle, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2016
Antimycobacterial activity of new N(1)-[1-[1-aryl-3-[4-(1H-imidazol-1-yl)phenyl]-3-oxo]propyl]-pyridine-2-carboxamidrazone derivativesDaniele Zampieri, Maria Grazia Mamolo, Luciano Vio, et al.
FEBS Letters|July 28, 2006
NF1 mRNA biogenesis: effect of the genomic milieu in splicing regulation of the NF1 exon 37 regionMarco Baralle, Natasa Skoko, Anna Knezevich, et al.
Disease Models & Mechanisms|March 4, 2022
Physiological tissue-specific and age-related reduction of mouse TDP-43 levels is regulated by epigenetic modificationsMiriam Pacetti, Laura De Conti, Luciano E Marasco, et al.
Nucleic Acids Research|December 27, 2013
Predominance of spliceosomal complex formation over polyadenylation site selection in TDP-43 autoregulationSara Bembich, Jeremias S Herzog, Laura De Conti, et al.
Experimental & Molecular Medicine|July 31, 2024
Tailored antisense oligonucleotides designed to correct aberrant splicing reveal actionable groups of mutations for rare genetic disordersHtoo A Wai, Eliska Svobodova, Natalia Romero Herrera, et al.
Human Mutation|July 17, 2010
Congenital insensitivity to pain: novel SCN9A missense and in-frame deletion mutationsJames J Cox, Jony Sheynin, Zamir Shorer, et al.
The EMBO Journal|December 7, 2010
TDP-43 regulates its mRNA levels through a negative feedback loopYouhna M Ayala, Laura De Conti, S Eréndira Avendaño-Vázquez, et al.
Translational Oncology|March 25, 2022
Force-feeding malignant mesothelioma stem-cell like with exosome-delivered miR-126 induces tumour cell killingFederica Monaco, Laura De Conti, Simone Vodret, et al.
Neurobiology of Disease|September 27, 2021
Thioridazine reverts the phenotype in cellular and Drosophila models of amyotrophic lateral sclerosis by enhancing TDP-43 aggregate clearanceLucia Cragnaz, Greta Spinelli, Laura De Conti, et al.
Pageof 5